VitaStir review

The starter price is one line in a rising kit schedule

The main semaglutide/B12 page lists four-injection kits from $125 to $395 across its prescribed-strength options. The main tirzepatide page, formulated with glycine and B12, lists $145 to $599. A price comparison should use the actual prescribed preparation and supply, not extend the least expensive option to every later purchase. ^{[1] [2]}

Both main kit pages list syringes, alcohol pads and physician access. Confirm the complete invoice and responsible clinical contact, including any additional fees. A shipping method described as two-day or overnight does not establish free shipping or guarantee that medical review and pharmacy processing finish within that same period.

Compare actual ongoing kit and shipping charges in the GLP-1 full-cost planner.

For a different package-total and quarterly-offer comparison, read our PeterMD package-and-renewal review.

The separate $99 listings need a different column

The SDV pages describe a one-week supply rather than a four-injection month. The semaglutide page also gives different single-injection and first-month figures in its pricing and ingredient sections. Tirzepatide’s SDV page gives differing first-month prices too. Those conflicts need a selected written quote; none establishes a universal $99 monthly plan. ^{[3] [4]}

The SDV tirzepatide page additionally mixes route wording. Have the prescriber and pharmacist identify the actual product and instructions rather than treating a generic webpage as an administration guide. A cheap headline is not useful when the supply or formulation remains ambiguous.

For separately labeled starter and continuing programs, read our Ivologist starter-and-maintenance review.

The combined ingredients are not an outcome guarantee

The tirzepatide pages promote glycine for muscle retention and B12 for nausea. These ingredient explanations do not demonstrate that the supplied combination prevents muscle loss or reduces adverse effects compared with an applicable alternative. Keep the compounded formulation distinct from branded-product trial results. ^{[2] [4]}

FDA does not approve compounded medicines before marketing. The terms also separate the platform from prescribing physicians and pharmacies; a general accreditation description does not establish the assigned dispenser for this prescription. The clinical review should explain why the actual preparation is appropriate and how problems reach the right professional. ^{[7] [8]}

Keep the trial products and populations clear with the semaglutide-versus-tirzepatide evidence.

The next bill may arrive before a calendar month is over

VitaStir’s refund policy says subscriptions recur every twenty-five days and must be canceled by email before the next charge. After billing, it says the subscription cannot be canceled or refunded. Confirm whether the selected order is recurring and put the processing date beside the supply period. ^[5]

The product pages promise a full refund if a physician declines approval, while the general policy describes homekits as nonrefundable. Clarify the order’s stage before relying on that exception. The FAQ also asks for delivery issues to be reported within forty-eight hours. Choose a specified kit and usable clinical follow-up after the full financial commitment is clear. ^{[1] [5] [6]}

Choose the care relationship as well as the supplied product with our clinical-access comparison.

Understanding the cost

Main four-injection pages list semaglutide $125–$395 and tirzepatide $145–$599 depending on the prescribed strength. Separate $99 SDV pages describe one-week supplies and contain price conflicts. Obtain the final product-specific invoice, shipping and 25-day renewal details.